Global Pharmaceuticals & Biotech Most Popular Stocks

Senti Biosciences

Market Cap: US$36.4m

A clinical stage biotechnology company, develops cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases.

Mural Oncology

Market Cap: US$36.2m

Operates as a clinical-stage oncology company that focuses on discovering and developing immunotherapies for the treatment of patients with cancer.

G.F.C Green Fields Capital

Market Cap: ₪121.3m

Does not have significant operations.

Mendus

Market Cap: SEK 339.9m

A biopharmaceutical company, develops immunotherapies for the treatment of tumor recurrence and established tumors.

NeuroScientific Biopharmaceuticals

Market Cap: AU$54.9m

Engages in the research and development of novel peptide-based pharmaceutical products.

ADBiotech

Market Cap: ₩50.6b

Develops and sells antibodies for livestock, fisheries, and humans in South Korea and internationally.

Bioqual

Market Cap: US$35.8m

Provides in-vivo and in-vitro pre-clinical research services to commercial and government clients in the United States.

Green Lifescience

Market Cap: ₩50.4b

Engages in development, production, and sale of agrochemical raw materials and pharmaceutical intermediates in South Korea and internationally.

Zenotech Laboratories

Market Cap: ₹3.2b

Manufactures and markets pharmaceutical specialty generic injectables in the oncology and anesthesiology markets in India.

Eagle Pharmaceuticals

Market Cap: US$35.2m

A pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States.

Promimic

Market Cap: SEK 329.7m

Manufactures, markets, and sells biomaterials for improved osseointegration for orthopedic and dental implants markets.

Rhone Ma Holdings Berhad

Market Cap: RM 147.6m

An investment holding company, engages in the manufacture, trading, marketing, and distribution of biotechnology and animal health products primarily in Malaysia.

Ulisse Biomed

Market Cap: €29.9m

A healthcare biotech company, develops, produces, and markets vitro diagnostic medical devices in Italy.

Delta-Fly Pharma

Market Cap: JP¥5.2b

Develops anticancer drugs.

Curasight

Market Cap: DKK 222.0m

Develops therapeutic and diagnostic solutions for the treatment of cancer.

Korean Drug

Market Cap: ₩48.9b

Manufactures and sells medicines for treating various diseases in South Korea.

Nicox

Market Cap: €29.5m

Operates as an ophthalmology company in France and internationally.

Biotoxtech

Market Cap: ₩48.7b

Engages in the safety evaluation of synthetic medicines, biomedicines, cell therapy products, gene therapy products, health functional foods, chemicals, and pesticides in South Korea.

Rani Therapeutics Holdings

Market Cap: US$34.5m

Operates as a clinical stage biotherapeutics company, focusing on technologies to enable the administration of biologics and drugs orally for patients, physicians, and healthcare systems with a alternative to painful injections in the United States.

Cynata Therapeutics

Market Cap: AU$52.2m

Engages in the development and commercialization of proprietary induced pluripotent stem cell and mesenchymal stem cell technology under the Cymerus brand for human therapeutic use in Australia.

ZYUS Life Sciences

Market Cap: CA$47.7m

Manufactures and distributes cannabinoid-based therapeutics and product candidates in Canada, the United States, Australia, and the European Union.

AN2 Therapeutics

Market Cap: US$34.2m

A biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics.

Eusol BiotechLtd

Market Cap: NT$1.0b

Focuses on research and development of new biotech drugs for sleep disorders.

OnKure Therapeutics

Market Cap: US$34.0m

A clinical-stage biopharmaceutical company, focuses on the discovery and development of precision medicines that target biologically validated drivers of cancers.

International Isotopes

Market Cap: US$33.7m

Manufactures and sells nuclear medicine calibration and reference standards, cobalt-60 products, sodium iodide I-131 drug product, and radiochemicals for clinical research and life sciences in the United States and internationally.

Labiana Health

Market Cap: €28.6m

Develops, manufactures, sells, and markets animal and human health medicine products in Spain, rest of European Union, and internationally.

Aligned Genetics

Market Cap: ₩47.0b

Offers cellular imaging and biomolecular analysis solutions worldwide.

Ascendis Health

Market Cap: R575.7m

A health and wellness company, manufactures and distributes healthcare products in South Africa.

LakeShore Biopharma

Market Cap: US$33.0m

A biopharmaceutical company, discovers, develops, manufactures, commercializes, and sells vaccines and therapeutic biologics for infectious diseases and cancer.

Kyung Nam PharmLtd

Market Cap: ₩46.4b

Engages in the manufacture and sale of pharmaceutical, cosmetic, chemical, and health functional food products in South Korea, North America, and rest of Asia.

Cyfuse Biomedical K.K

Market Cap: JP¥4.9b

Engages in the development, manufacture, and sale of regenerative medicine products in Japan.

SynCore BiotechnologyLtd

Market Cap: NT$989.9m

Engages in development and sale of food advisory, medicine inspection, and biotechnology service in Taiwan.

Poltreg

Market Cap: zł117.5m

A biotechnology company, researches and develops therapies for autoimmune diseases.

genOway Société anonyme

Market Cap: €27.5m

A biotechnology company, engages in the development and commercialization of custom genetically modified mouse, rat, and cell line models worldwide.

Iterum Therapeutics

Market Cap: US$32.1m

A pharmaceutical company, develops and commercializes treatments for drug resistant bacterial infections in Ireland, Bermuda, and the United States.

Sanjivani Paranteral

Market Cap: ₹2.8b

Operates as a pharmaceutical company in India.